Margaret Fischl, an infectious disease physician and scientist with the University of Miami Health System and Miller School of Medicine, and UM clinical research nurses demonstrate the needle-free injector that will be used to administer an experimental Zika vaccine in a Phase 2 trial led by the National Institutes of Health. Vaccinations have begun in Miami, Houston and Puerto Rico as part of a clinical trial testing an experimental DNA vaccine designed to protect against disease caused by Zika.
Margaret Fischl, an infectious disease physician and scientist with the University of Miami Health System and Miller School of Medicine, and UM clinical research nurses demonstrate the needle-free injector that will be used to administer an experimental Zika vaccine in a Phase 2 trial led by the National Institutes of Health. Vaccinations have begun in Miami, Houston and Puerto Rico as part of a clinical trial testing an experimental DNA vaccine designed to protect against disease caused by Zika. University of Miami
Margaret Fischl, an infectious disease physician and scientist with the University of Miami Health System and Miller School of Medicine, and UM clinical research nurses demonstrate the needle-free injector that will be used to administer an experimental Zika vaccine in a Phase 2 trial led by the National Institutes of Health. Vaccinations have begun in Miami, Houston and Puerto Rico as part of a clinical trial testing an experimental DNA vaccine designed to protect against disease caused by Zika. University of Miami

Clinical trial to begin in Miami for Zika vaccine

March 31, 2017 6:26 PM